background: the aim was to evaluate the relapse risk of vivax malaria in patients who received radical treatment in hormozgan province, a malarious area located on southeast of iran. methods: a total of 95 symptomatic vivax malaria infected patients were enrolled in urban health centers of bandar - abbas, minab, bandar-jask and bashagard districts of hormozgan province, southeast of iran from j...